Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunomodulatory Effects of Volatile and Total Intravenous Anesthesia for Patients With Renal Cancer

NCT03514550 is registered in ClinicalTrials.gov with Meshalkin Research Institute of Pathology of Circulation as lead sponsor.

NCT NCT03514550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03514550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunomodulatory Effects of Volatile and Total Intravenous Anesthesia for Patients With Renal Cancer
Lead sponsor
Meshalkin Research Institute of Pathology of Circulation
Phase
Phase 4
Overall status
Completed
Start date
May 14, 2018
Completion date
May 20, 2019
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal cancer, surgery